Back to Journals » OncoTargets and Therapy » Volume 6

Review

Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities

      
Total article views   HTML views PDF downloads Totals
10,477 Dovepress* 8,032+ 1,692 9,724
PubMed Central* 2,445 1,182 3,627
Totals 10,477 2,874 13,351
*Since 24 July 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar